Koning Breast CT (KBCT)-Guided Neoadjuvant Treatment of Breast Cancer Monitoring Phase I Trial
Observational Model: Case-Only, Time Perspective: Prospective
Tumor volume change from baseline during neoadjuvant treatment
Tumor volume will be measured with KBCT imaging at the beginning of the therapy (baseline), mid-point of the therapy (about 3 months after the treatment starts) and end of therapy (about 4-6 months after the treatment starts). The volume change from the baseline during the treatment will be recorded. Adverse Events will be recorded as a measure of safety.
Baseline, mid-point (~3 months), and end of therapy (4-6 months)
United States: Institutional Review Board
|University of Rochester Medical Center Highland Breast Imaging Center||Rochester, New York 14623|